| 1H-NMR–based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants N Serkova, TF Fuller, J Klawitter, CE Freise, CU Niemann Kidney international 67 (3), 1142-1151, 2005 | 209 | 2005 |
| Everolimus and sirolimus in transplantation-related but different J Klawitter, B Nashan, U Christians Expert opinion on drug safety 14 (7), 1055-1070, 2015 | 169 | 2015 |
| Effects of lovastatin on breast cancer cells: a proteo-metabonomic study J Klawitter, T Shokati, V Moll, U Christians, J Klawitter Breast cancer research 12, 1-20, 2010 | 129 | 2010 |
| Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice A Grenz, JD Bauerle, JH Dalton, D Ridyard, A Badulak, E Tak, ... The Journal of clinical investigation 122 (2), 693-710, 2012 | 126 | 2012 |
| Development and validation of an assay for the quantification of 11 nucleotides using LC/LC–electrospray ionization–MS J Klawitter, V Schmitz, J Klawitter, D Leibfritz, U Christians Analytical biochemistry 365 (2), 230-239, 2007 | 110 | 2007 |
| Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values AD Leino, EC King, W Jiang, AA Vinks, J Klawitter, U Christians, ... American Journal of Transplantation 19 (5), 1410-1420, 2019 | 98 | 2019 |
| Endothelial dysfunction and oxidative stress in polycystic kidney disease J Klawitter, BY Reed-Gitomer, K McFann, A Pennington, J Klawitter, ... American Journal of Physiology-Renal Physiology 307 (11), F1198-F1206, 2014 | 98 | 2014 |
| Quantification of 15‐F2t‐isoprostane in human plasma and urine: results from enzyme‐linked immunoassay and liquid chromatography/tandem mass spectrometry … J Klawitter, M Haschke, T Shokati, J Klawitter, U Christians Rapid Communications in Mass Spectrometry 25 (4), 463-468, 2011 | 91 | 2011 |
| Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells J Klawitter, DJ Kominsky, JL Brown, J Klawitter, U Christians, D Leibfritz, ... British journal of pharmacology 158 (2), 588-600, 2009 | 84 | 2009 |
| Safety and tolerability of cannabidiol in Parkinson disease: an open label, dose-escalation study MA Leehey, Y Liu, F Hart, C Epstein, M Cook, S Sillau, J Klawitter, ... Cannabis and cannabinoid research 5 (4), 326-336, 2020 | 69 | 2020 |
| Association of naturalistic administration of cannabis flower and concentrates with intoxication and impairment LC Bidwell, JM Ellingson, HC Karoly, SL YorkWilliams, LN Hitchcock, ... JAMA psychiatry 77 (8), 787-796, 2020 | 68 | 2020 |
| Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose J Klawitter, M Haschke, C Kahle, C Dingmann, J Klawitter, D Leibfritz, ... British journal of clinical pharmacology 70 (2), 241-251, 2010 | 67 | 2010 |
| An atmospheric pressure chemical ionization MS/MS assay using online extraction for the analysis of 11 cannabinoids and metabolites in human plasma and urine J Klawitter, C Sempio, S Mörlein, E De Bloois, J Klepacki, T Henthorn, ... Therapeutic Drug Monitoring 39 (5), 556-564, 2017 | 62 | 2017 |
| A relative L‐arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition J Klawitter, KL Hildreth, U Christians, WM Kohrt, KL Moreau Physiological reports 5 (17), e13409, 2017 | 62 | 2017 |
| Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function J Klawitter, J Bendrick-Peart, B Rudolph, V Beckey, J Klawitter, ... Chemical Research in Toxicology 22 (1), 118-128, 2009 | 61 | 2009 |
| Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study J Klawitter, N Anderson, U Christians, D Leibfritz, SG Eckhardt, ... British journal of cancer 100 (6), 923-931, 2009 | 59 | 2009 |
| Bioactive lipid mediators in polycystic kidney disease J Klawitter, J Klawitter, K McFann, AT Pennington, KZ Abebe, ... Journal of lipid research 55 (6), 1139-1149, 2014 | 58 | 2014 |
| A high-throughput U-HPLC–MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide … J Klepacki, J Klawitter, J Bendrick-Peart, B Schniedewind, S Heischmann, ... Journal of Chromatography B 883, 113-119, 2012 | 58 | 2012 |
| Association of DJ-1/PTEN/AKT-and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy J Klawitter, J Klawitter, E Agardi, K Corby, D Leibfritz, BD Lowes, ... Cardiovascular research 97 (1), 66-76, 2013 | 57 | 2013 |
| Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges U Christians, V Schmitz, W Schöning, J Bendrick-Peart, J Klawitter, ... Therapeutic drug monitoring 30 (2), 151-158, 2008 | 54 | 2008 |
